tetradecanoylphorbol acetate has been researched along with Heart Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, H; Dong, L; Li, HW; Li, M; Wang, P; Wang, YP; Wu, YQ | 1 |
| Islam, KN; Koch, WJ | 1 |
2 other study(ies) available for tetradecanoylphorbol acetate and Heart Diseases
| Article | Year |
|---|---|
Relaxin inhibit cardiac fibrosis induced by phorbol 12-myristate 13-acetate.
Topics: Animals; Animals, Newborn; Cells, Cultured; Fibroblasts; Fibrosis; Heart Diseases; Rats; Rats, Sprague-Dawley; Relaxin; Tetradecanoylphorbol Acetate | 2014 |
Involvement of nuclear factor κB (NF-κB) signaling pathway in regulation of cardiac G protein-coupled receptor kinase 5 (GRK5) expression.
Topics: Acetylcysteine; Animals; G-Protein-Coupled Receptor Kinase 5; Gene Expression Regulation, Enzymologic; Heart Diseases; Myocytes, Cardiac; NF-kappa B p50 Subunit; Primary Cell Culture; Promoter Regions, Genetic; Rats; Reactive Oxygen Species; RNA, Small Interfering; Signal Transduction; Tetradecanoylphorbol Acetate; Thiophenes; Transcription Factor RelA | 2012 |